ClouDr Group Limited
ClouDr Group Limited (9955.HK) Stock Competitors & Peer Comparison
See (9955.HK) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 9955.HK | HK$0.72 | +4.35% | 452M | -0.38 | -HK$1.82 | N/A |
| 2607.HK | HK$11.94 | +3.38% | 67.7B | 6.75 | HK$1.73 | +3.74% |
| 1099.HK | HK$20.92 | +2.55% | 63B | 7.80 | HK$2.59 | +3.60% |
| 2192.HK | HK$8.61 | +1.53% | 6.4B | 17.06 | HK$0.51 | +3.17% |
| 1931.HK | HK$1.12 | +4.67% | 1.8B | 9.42 | HK$0.12 | N/A |
| 2289.HK | HK$5.81 | +0.00% | 627.5M | 11.86 | HK$0.49 | +8.42% |
| 0673.HK | HK$0.52 | +0.00% | 252.9M | -5.20 | -HK$0.10 | N/A |
| 0718.HK | HK$0.03 | -9.09% | 173.3M | -0.25 | -HK$0.13 | N/A |
| 8372.HK | HK$0.13 | +2.34% | 104.8M | 13.10 | HK$0.01 | +1.91% |
| 0401.HK | HK$0.11 | -11.72% | 70.6M | -12.60 | -HK$0.01 | N/A |
Stock Comparison
9955.HK vs 2607.HK Comparison April 2026
9955.HK plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 9955.HK stands at 452M. In comparison, 2607.HK has a market cap of 67.7B. Regarding current trading prices, 9955.HK is priced at HK$0.72, while 2607.HK trades at HK$11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
9955.HK currently has a P/E ratio of -0.38, whereas 2607.HK's P/E ratio is 6.75. In terms of profitability, 9955.HK's ROE is -0.67%, compared to 2607.HK's ROE of +0.08%. Regarding short-term risk, 9955.HK is more volatile compared to 2607.HK. This indicates potentially higher risk in terms of short-term price fluctuations for 9955.HK.Check 2607.HK's competition here